TRON Seminar in Translational Oncology: Prof. Dr. Sjoerd H. van der Burg and Dr. Thorbald van Hall

September 12, 2013

5 PM in Mainz, Germany

TRON – Building 708 at University Medical Center Mainz

Langenbeckstr. 1

55131 Mainz

Prof. Dr. Sjoerd H. van der Burg and Prof. Dr. Thorbald van Hall

Leiden University Medical CenterLeiden, Netherlands


“TEIPP – T Cell Epitopes associated with Impaired Peptide Processing”

Sjoerd H. van der Burg leads the experimental cancer immunology and therapy group at the Department of Clinical Oncology at Leiden University Medical Center.. Dr. van der Burg’s laboratory focuses on immunomonitoring and immunotherapy of solid tumors. His special research interest is in experimental cancer immunology with an emphasis on local immune response, T-helper cells, regulatory T cells and cytotoxic T cells in tumor immunity, as well as in cancer immunotherapy, in particular the development of therapeutic vaccine strategies and adoptive transfer of ex-vivo expanded T cells.

Thorbald van Hall is Associate Professor at the department of Clinical Oncology at Leiden University Medical Center. The research projects of Dr. van Hall focus on T-cell immunity to cancer, with a special interest for tumors with defects in antigen presentation.

At TRON, van der Burg and van Hall will present their discovery of a novel category of tumor antigens designated as TEIPP.

For further information on the work of van der Burg and van Hall, please see here.